Literature DB >> 376986

The transseptal approach to lesions of the pituitary and parasellar regions.

E B Kern, B W Pearson, T J McDonald, E R Laws.   

Abstract

In a series of 505 consecutive procedures, the transseptal-transsphenoidal pituitary operation has proved safe and effective. The overall mortality in this series is 1.39%. A wide variety of sphenoid and sellar lesions and nearly every pituitary adenoma have been found suitable for the exposure provided through the sublabial-transseptal approach. This statement rests on the premise that both the rhinologist's and the neurosurgeon's skills are optimally applied to each case. The role of the otorhinolaryngologist is defined in this paper, and the benefits of the team approach are explored. An interpretive history of the transsphenoidal approach is presented, and the evolution of the transseptal technique developed at the Mayo Clinic from 1972 to 1978 is reviewed. Emphasizing the rhinologic aspects, all details of the surgical technique are described and illustrated. Our experience with the special endocrine syndromes is also reviewed to spotlight clinical features that require individual consideration by the rhinologic surgeon.

Entities:  

Mesh:

Year:  1979        PMID: 376986     DOI: 10.1288/00005537-197905001-00001

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Fibrin tissue adhesive sealant for the prevention of CSF leakage following transsphenoidal microsurgery.

Authors:  V Van Velthoven; G Clarici; L M Auer
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

2.  Perioperative complications of transseptosphenoidal excision for pituitary adenomas.

Authors:  M S Persky; E Brunner; P R Cooper; N L Cohen
Journal:  Skull Base Surg       Date:  1996

Review 3.  The implications of microsurgical anatomy for surgical approaches to the sellar region.

Authors:  Gustavo Rassier Isolan; Paulo Henrique Pires de Aguiar; Edward R Laws; Atahualpa Cauê Paim Strapasson; Otávio Piltcher
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.